Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-20-035195
Filing Date
2020-12-28
Accepted
2020-12-28 16:30:11
Documents
1
Period of Report
2020-12-22

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3711
  Complete submission text file 0000899243-20-035195.txt   5372
Mailing Address 4830 W. KENNEDY BLVD. SUITE 600 TAMPA FL 33609
Business Address 4830 W. KENNEDY BLVD. SUITE 600 TAMPA FL 33609 (813) 766-2462
Inhibitor Therapeutics, Inc. (Issuer) CIK: 0001042418 (see all company filings)

EIN.: 541641133 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address C/O HEDGEPATH PHARMACEUTICALS, INC. 324 SOUTH HYDE PARK AVENUE, SUITE 350 TAMPA FL 33606
Business Address
Martin Robert Daniel (Reporting) CIK: 0001509322 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-13467 | Film No.: 201418656